• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epidemiol Infect . SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital

tetano

Editor, Senior Moderator
Epidemiol Infect


. 2021 Aug 10;149:e172.
doi: 10.1017/S0950268821001497.
SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital


Reinout Naesens[SUP] 1 2 [/SUP], Helena Mertes[SUP] 3 [/SUP], Johan Clukers[SUP] 4 [/SUP], Sereina Herzog[SUP] 5 [/SUP], Christiane Brands[SUP] 3 [/SUP], Philippe Vets[SUP] 6 [/SUP], Inneke De Laet[SUP] 6 [/SUP], Peggy Bruynseels[SUP] 1 2 [/SUP], Pieter De Schouwer[SUP] 1 [/SUP], Sanne van der Maas[SUP] 7 [/SUP], Katrien Bervoets[SUP] 7 [/SUP], Niel Hens[SUP] 5 8 [/SUP], Pierre Van Damme[SUP] 5 9 [/SUP]



Affiliations

Abstract

Although the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is lasting for more than 1 year, the exposition risks of health-care providers are still unclear. Available evidence is conflicting. We investigated the prevalence of antibodies against SARS-CoV-2 in the staff of a large public hospital with multiple sites in the Antwerp region of Belgium. Risk factors for infection were identified by means of a questionnaire and human resource data. We performed hospital-wide serology tests in the weeks following the first epidemic wave (16 March to the end of May 2020) and combined the results with the answers from an individual questionnaire. Overall seroprevalence was 7.6%. We found higher seroprevalences in nurses [10.0%; 95% confidence interval (CI) 8.9-11.2] than in physicians 6.4% (95% CI 4.6-8.7), paramedical 6.0% (95% CI 4.3-8.0) and administrative staff (2.9%; 95% CI 1.8-4.5). Staff who indicated contact with a confirmed coronavirus disease 2019 (COVID-19) colleague had a higher seroprevalence (12.0%; 95% CI 10.7-13.4) than staff who did not (4.2%; 95% CI 3.5-5.0). The same findings were present for contacts in the private setting. Working in general COVID-19 wards, but not in emergency departments or intensive care units, was also a significant risk factor. Since our analysis points in the direction of active SARS-CoV-2 transmission within hospitals, we argue for implementing a stringent hospital-wide testing and contact-tracing policy with special attention to the health care workers employed in general COVID-19 departments. Additional studies are needed to establish the transmission dynamics.

Keywords: SARS-CoV-2; health care worker; professional category; risk factor; seroprevalence.
 
Back
Top Bottom